Marieke Schurer, principal insight analyst, HEOR at Lumanity
Marieke completed a master’s degree in Health Care Management at the Erasmus University Rotterdam in the Netherlands and has a background in biomedical sciences.
She is a passionate qualitative researcher who joined Lumanity (legacy BresMed) in 2014. Marieke has experience in a range of different research methods that she employs in patient-focused research, to ensure the patient voice is heard in HTA and the wider HEOR setting.
Ann-Marie Chapman, head of insight, HEOR at Lumanity
Ann-Marie joined the company in 2014, when the company was known as BresMed, and has over 18 years of experience in health economics and outcomes research across the consultancy, pharmaceutical, and medical technology industries.
Ann-Marie has wide-ranging experience in supporting health technology assessment submissions, new product implementation, and stakeholder engagement with appropriate value messages.
Lumanity applies incisive thinking and decisive action to cut through complex situations and deliver transformative outcomes to accelerate and optimise access to medical advances. By transforming data and information into real world insights and evidence, Lumanity powers successful commercialisation and empowers patients, providers, payers, and regulators to take timely and decisive action.
With offices in North America, the United Kingdom, the European Union, and Asia, and work conducted in over 50 countries, its 1,200+ experts work with nearly all the top pharmaceutical companies and more than 100 biotech companies around the world. Turning aspiration into reality, Lumanity supports over 50 payer submissions across 20+ countries, launch readiness and commercialisation of 80 brands and new indications, and numerous award-winning product campaigns every year.